About us
We are curious, bold, and share a passion for thinking differently.
We are dedicated to improving the health and well-being of patients in Canada through innovative treatments curated by cutting-edge science and technology dedicated to improving the health and well-being of people around the world through innovative science and technology.
Sumitomo Pharma Canada is a Sumitomo Pharma America (SMPA) company. SMPA is focused on accelerating patient-needed therapies in psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapy.
Learn more about SMPA.
Our Reach
Global reach with an expansive U.S. footprint
Sumitomo Pharma Canada, Inc. is part of a global ecosystem of companies working on innovative research and development activities to transform health care and improve the lives of people worldwide. This global ecosystem has a geographic footprint spanning Japan, the U.S., China, Canada, and Europe as well as talent, knowledge, and resources across a wide spectrum of technologies and therapeutic areas.
